Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Artificial Intelligence(AI)-based solutions for Gleason grading hold promise for pathologists, while image quality inconsistency, continuous data integration needs, and limited generalizability hinder their adoption and scalability.

Methods: We present a comprehensive digital pathology workflow for AI-assisted Gleason grading. It incorporates A!MagQC (image quality control), A!HistoClouds (cloud-based annotation), Pathologist-AI Interaction (PAI) for continuous model improvement, Trained on Akoya-scanned images only, the model utilizes color augmentation and image appearance migration to address scanner variations. We evaluate it on Whole Slide Images (WSI) from another five scanners and conduct validations with pathologists to assess AI efficacy and PAI.

Results: Our model achieves an average F1 score of 0.80 on annotations and 0.71 Quadratic Weighted Kappa on WSIs for Akoya-scanned images. Applying our generalization solution increases the average F1 score for Gleason pattern detection from 0.73 to 0.88 on images from other scanners. The model accelerates Gleason scoring time by 43% while maintaining accuracy. Additionally, PAI improve annotation efficiency by 2.5 times and led to further improvements in model performance.

Conclusions: This pipeline represents a notable advancement in AI-assisted Gleason grading for improved consistency, accuracy, and efficiency. Unlike previous methods limited by scanner specificity, our model achieves outstanding performance across diverse scanners. This improvement paves the way for its seamless integration into clinical workflows.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082180PMC
http://dx.doi.org/10.1038/s43856-024-00502-1DOI Listing

Publication Analysis

Top Keywords

gleason grading
16
image quality
8
ai-assisted gleason
8
akoya-scanned images
8
model achieves
8
average score
8
gleason
6
model
6
comprehensive model
4
model development
4

Similar Publications

Comparison of clinical features between patients with bone and soft tissue angiosarcomas.

J Orthop Sci

September 2025

Department of Orthopedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, North 15 West 7, Kita-Ku, Sapporo, Hokkaido 060-8638, Japan. Electronic address:

Background: Angiosarcoma is a rare and aggressive malignancy arising from vascular endothelial cells, with distinct subtypes originating in bone (AS-B) and soft tissue (AS-ST). While these subtypes share pathological similarities, differences in clinical outcomes remain unclear due to limited data. This study aimed to compare the clinical features, treatment strategies, and survival outcomes between AS-B and AS-ST using the Surveillance, Epidemiology, and End Results (SEER) database.

View Article and Find Full Text PDF

Breast cancer is a heterogeneous disease in which estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 play crucial roles in molecular subtyping, diagnosis, treatment, and prognosis, showing positivity in nearly 90% of cases. The vitamin D receptor (VDR) has been implicated in the oncogenesis and prognosis of various tumors, but its relationship with molecular subtyping factors in breast carcinomas remains to be clarified. This retrospective cross-sectional study included 111 patients who underwent surgery for breast carcinoma.

View Article and Find Full Text PDF

Ki67 is a broadly available biomarker of proliferation with various approaches to its evaluation in breast cancer. The International Ki67 in Breast Cancer Working Group (IKWG) recommends calculating Ki67 globally across the tumor area, as this method offers high interobserver concordance. These recommendations have been integrated into many international breast cancer guidelines (ASCO, ESMO), yet there is no real-world data on if it improved inter-pathologists and inter-laboratory variability.

View Article and Find Full Text PDF

Background: Poly-ADP ribose polymerase inhibitors have been shown to improve progression-free survival in patients with advanced high-grade epithelial non-mucinous ovarian cancers characterized by a deficiency in homologous recombination (HRD). Guidelines recommend all patients with advanced high-grade epithelial ovarian cancer undergo genomic tumor testing for HRD. Our aim was to evaluate the first year of HRD testing at the statewide Western Australia Gynecologic Cancer Service to assess factors associated with obtaining a diagnostic HRD testing result.

View Article and Find Full Text PDF

Pediatric high-grade gliomas (pHGG) are highly invasive with poor survival outcomes. Timing of Temozolomide administration has been shown to affect survival of adult patients with glioblastoma. We investigated whether pHGGs express circadian genes rhythmically and whether underlying rhythms affect Temozolomide sensitivity.

View Article and Find Full Text PDF